23
Participants
Start Date
February 28, 2003
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
imatinib mesylate
Given orally
laboratory biomarker analysis
Correlative studies
pharmacological study
Correlative studies
Memorial Sloan-Kettering Cancer Center, New York
National Cancer Institute Neuro-Oncology Branch, Bethesda
University of Wisconsin, Madison
University of Texas Southwestern Medical Center, Dallas
University of California Los Angeles, Los Angeles
University of California San Francisco, San Francisco
Dana Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH